Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Magnitude Biosciences is a specialist contract research organization (CRO) that provides automated C. elegans services to accelerate drug discovery and product development in the pharmaceutical and nutraceutical industries. The company utilizes its proprietary WormGazer technology, an automated imaging and data analysis platform, to monitor the effects of compounds on the health and lifespan of nematode worms. Their services are particularly focused on aging, neurodegeneration, and metabolic health, offering a cost-effective and high-throughput alternative to traditional mammalian models. Magnitude Biosciences supports clients in identifying lead compounds, validating targets, and generating physiological data to de-risk early-stage research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Magnitude Nutrition.